Skip to main content

Therapeutics Startups

Updated July 2026

Companies in the therapeutics sector developing innovative solutions and technologies.

Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.

Total Companies
1,708
Total Funding
$1.9B
Avg Funding
$77.2M
Global Reach
3
countries

Top Cities for Therapeutics

Cambridge
Munich
Waltham
San Francisco
Blue Bell
Edinburgh

Recently Funded Companies

Export
Cambridge, United Kingdom

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

$13.3M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Munich, Germany

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

$400.6M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Waltham, United States

Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.

$600.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Expedition Therapeutics is a biotechnology company that develops novel therapies for inflammatory and respiratory diseases.

$165.0M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Blue Bell, United States

Ladder Bio is a therapeutics company that develops synthetic, ladder-shaped compounds engineered for high specificity and stability.

$5.5M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.

$9.3M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

Trogenix is a biotech company that develops precision cancer treatments that selectively target diseased cell states and behaviour.

$94.1M raised
Oct 2025

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.

$125.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Portland, United States

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

$95.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Missoula, United States

FYR Diagnostics develops biomarker detection technology to combat chronic diseases in both human healthcare and agriculture.

$8.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Scottsdale, United States

Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.

$14.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Micro Medical Solutions is a developer of microvascular intervention therapies used for patients with peripheral artery disease.

$4.8M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

$53.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.

$6.7M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Jersey City, United States

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

$17.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Gladwyne, United States

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

$11.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

$5.4M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Vestavia Hills, United States

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

$8.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates.

$59.1M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

La Jolla, United States

Enlaza Therapeutics is a biotechnology research company.

$15.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Houston, United States

Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell.

$5.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Baltimore, United States

Kubanda Cryotherapy offers minimally invasive, non-surgical treatment for lumps, bumps, and cancers in pets.

$500K raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Rostock, Germany

Artcline is a biotechnology company that develops diagnostic and therapeutic procedures for intensive care medicine.

$5.9M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Boulder, United States

Enveda Biosciences is a biotechnology company that develops novel medications derived from plants.

$150.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

$60.0M raised
Sep 2025

Founder Contacts

30,000+ verified contacts

Showing 926 to 950 of 1,708 companies

About the Therapeutics Startup Ecosystem

The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Therapeutics

Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Therapeutics Funding Breakdown

Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.

Average Funding
$77.2M
Total Funding Tracked
$1.9B
Countries Represented
3

Distribution by Funding Stage

Other25 companies

Top Cities for Therapeutics

1.San Francisco
2 companies$174.3M
2.Boston
2 companies$112.1M
3.San Diego
2 companies$65.4M
4.Cambridge
1 companies$13.3M
5.Munich
1 companies$400.6M

Related Industries

Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Therapeutics Startups?

Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked